BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35125537)

  • 1. Maintaining essential tuberculosis services during the COVID-19 pandemic, Philippines.
    Calnan M; Moran A; Jassim AlMossawi H
    Bull World Health Organ; 2022 Feb; 100(2):127-134. PubMed ID: 35125537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on tuberculosis management in Spain.
    Aznar ML; Espinosa-Pereiro J; Saborit N; Jové N; Sánchez Martinez F; Pérez-Recio S; Vitoria A; Sanjoaquin I; Gallardo E; Llenas-García J; Pomar V; García IO; Cacho J; Goncalves De Freitas L; San Martin JV; García Rodriguez JF; Jiménez-Fuentes MÁ; De Souza-Galvao ML; Tórtola T; Zules R; Molina I; Sánchez-Montalvá A
    Int J Infect Dis; 2021 Jul; 108():300-305. PubMed ID: 33930543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences, challenges and looking to the future in a clinical tuberculosis cohort in the time of COVID-19 in the Philippines.
    Ferrer JP; Suzuki S; Alvarez C; Berido C; Caballero M; Caraig B; Flores PI; Juson RJ; Lustresano A; Opinion T; Saavedra M; Verde A; Faguer BN; Cox SE; Solon JA
    Trans R Soc Trop Med Hyg; 2021 Jun; 115(6):579-582. PubMed ID: 33693916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrupted time-series analysis of active case-finding for tuberculosis during the COVID-19 pandemic, Zambia.
    Lungu PS; Kerkhoff AD; Muyoyeta M; Kasapo CC; Nyangu S; Kagujje M; Chimzizi R; Nyimbili S; Khunga M; Kasese-Chanda N; Musonda V; Tambatamba B; Kombe CM; Sakulanda C; Sampa K; Silumesii A; Malama K
    Bull World Health Organ; 2022 Mar; 100(3):205-215. PubMed ID: 35261409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Was the Change in Telehealth Usage and Proportion of No-show Visits for an Orthopaedic Trauma Clinic During the COVID-19 Pandemic?
    Siow MY; Walker JT; Britt E; Kozy JP; Zanzucchi A; Girard PJ; Schwartz AK; Kent WT
    Clin Orthop Relat Res; 2020 Oct; 478(10):2257-2263. PubMed ID: 32639309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19.
    Sy KTL; Haw NJL; Uy J
    Infect Dis (Lond); 2020; 52(12):902-907. PubMed ID: 32808838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey.
    Nkereuwem O; Nkereuwem E; Fiogbe A; Usoroh EE; Sillah AK; Owolabi O; Tebruegge M; Badjan A; Kampmann B; Togun T
    BMC Health Serv Res; 2021 Aug; 21(1):798. PubMed ID: 34384439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial.
    Lai KSP; Watt C; Ionson E; Baruss I; Forchuk C; Sukhera J; Burhan AM; Vasudev A
    Trials; 2020 Jul; 21(1):648. PubMed ID: 32665041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study.
    Adelekan B; Goldson E; Abubakar Z; Mueller U; Alayande A; Ojogun T; Ntoimo L; Williams B; Muhammed I; Okonofua F
    Reprod Health; 2021 Aug; 18(1):166. PubMed ID: 34348757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa.
    Loveday M; Cox H; Evans D; Furin J; Ndjeka N; Osman M; Naidoo For The National Tb Think Tank 'Optimising Tb Treatment Outcomes' Task Team K
    S Afr Med J; 2020 Nov; 110(12):1160-1167. PubMed ID: 33403958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Homolka S; Paulowski L; Andres S; Hillemann D; Jou R; Günther G; Claassens M; Kuhns M; Niemann S; Maurer FP
    Emerg Infect Dis; 2020 Nov; 26(11):2549-2554. PubMed ID: 32956612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
    Tirupakuzhi Vijayaraghavan BK; Jha V; Rajbhandari D; Myatra SN; John O; Ghosh A; Bassi A; Arfin S; Kunigari M; Joshi R; Donaldson L; Hammond N; Venkatesh B;
    Trials; 2020 Aug; 21(1):754. PubMed ID: 32867852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
    Rodler S; Apfelbeck M; Schulz GB; Ivanova T; Buchner A; Staehler M; Heinemann V; Stief C; Casuscelli J
    Eur Urol Focus; 2020 Sep; 6(5):1097-1103. PubMed ID: 32534969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
    Migliori GB; Thong PM; Akkerman O; Alffenaar JW; Álvarez-Navascués F; Assao-Neino MM; Bernard PV; Biala JS; Blanc FX; Bogorodskaya EM; Borisov S; Buonsenso D; Calnan M; Castellotti PF; Centis R; Chakaya JM; Cho JG; Codecasa LR; D'Ambrosio L; Denholm J; Enwerem M; Ferrarese M; Galvão T; García-Clemente M; García-García JM; Gualano G; Gullón-Blanco JA; Inwentarz S; Ippolito G; Kunst H; Maryandyshev A; Melazzini M; de Queiroz Mello FC; Muñoz-Torrico M; Njungfiyini PB; Palmero DJ; Palmieri F; Piccioni P; Piubello A; Rendon A; Sabriá J; Saporiti M; Scognamiglio P; Sharma S; Silva DR; Souleymane MB; Spanevello A; Tabernero E; Tadolini M; Tchangou ME; Thornton ABY; Tiberi S; Udwadia ZF; Sotgiu G; Ong CWM; Goletti D
    Emerg Infect Dis; 2020 Nov; 26(11):2709-2712. PubMed ID: 32917293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.